Cargando…

Association between circadian gene CLOCK and cisplatin resistance in ovarian cancer cells: A preliminary study

The present study aimed to observe the expression of circadian gene clock circadian regulator (CLOCK) in ovarian cancer cells and the effects of circadian gene CLOCK on cis-dichlorodiamine platinum (cisplatin) resistance in ovarian cancer cells. The expression of CLOCK mRNA and protein in cisplatin-...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Hai, Wang, Zhiyin, Mo, Guoyan, Chen, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958788/
https://www.ncbi.nlm.nih.gov/pubmed/29844814
http://dx.doi.org/10.3892/ol.2018.8488
_version_ 1783324293303631872
author Xu, Hai
Wang, Zhiyin
Mo, Guoyan
Chen, Hao
author_facet Xu, Hai
Wang, Zhiyin
Mo, Guoyan
Chen, Hao
author_sort Xu, Hai
collection PubMed
description The present study aimed to observe the expression of circadian gene clock circadian regulator (CLOCK) in ovarian cancer cells and the effects of circadian gene CLOCK on cis-dichlorodiamine platinum (cisplatin) resistance in ovarian cancer cells. The expression of CLOCK mRNA and protein in cisplatin-sensitive A2780 and cisplatin-resistant CP70 cells were detected by quantitative polymerase chain reaction and western blot assay. Cisplatin-sensitive A2780 and cisplatin-resistant CP70 cells were treated with different concentrations of cisplatin for 48 h, and the expression of hCLOCK protein in the two types of cells was detected by western blot assay. RNA interference method was used to knock down the expression of CLOCK in cisplatin-resistant CP70 cells. Subsequently, the cisplatin-resistant CP70 cells were treated with cisplatin. The proliferation of cisplatin-resistant CP70 cells was observed following treatment with cisplatin. The expression of CLOCK mRNA was significantly higher in cisplatin-resistant CP70 cells (1.58±0.49) compared with cisplatin-sensitive A2780 cells (0.44±0.13) (P<0.01). Western blot assay results demonstrated that the expression of CLOCK protein was significantly greater in the cisplatin-resistant CP70 cells (1.47±0.34) compared with the cisplatin-sensitive A2780 cells (0.48±0.15) (P<0.01). Following the treatment of A2780 and CP70 cells with cisplatin, CLOCK protein expression increased with an increased concentration of cisplatin, in a dose-dependent manner (P<0.01). Following the knockdown of CLOCK in cisplatin-resistant CP70 cells by RNA interference, cisplatin treatment was able to significantly inhibit the proliferation of cells and induce apoptosis (P<0.01). The expression of circadian gene CLOCK in ovarian cancer cells was strongly associated with cisplatin resistance. The upregulation of circadian gene CLOCK in ovarian cancer cells may reduce its sensitivity to cisplatin treatment.
format Online
Article
Text
id pubmed-5958788
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-59587882018-05-29 Association between circadian gene CLOCK and cisplatin resistance in ovarian cancer cells: A preliminary study Xu, Hai Wang, Zhiyin Mo, Guoyan Chen, Hao Oncol Lett Articles The present study aimed to observe the expression of circadian gene clock circadian regulator (CLOCK) in ovarian cancer cells and the effects of circadian gene CLOCK on cis-dichlorodiamine platinum (cisplatin) resistance in ovarian cancer cells. The expression of CLOCK mRNA and protein in cisplatin-sensitive A2780 and cisplatin-resistant CP70 cells were detected by quantitative polymerase chain reaction and western blot assay. Cisplatin-sensitive A2780 and cisplatin-resistant CP70 cells were treated with different concentrations of cisplatin for 48 h, and the expression of hCLOCK protein in the two types of cells was detected by western blot assay. RNA interference method was used to knock down the expression of CLOCK in cisplatin-resistant CP70 cells. Subsequently, the cisplatin-resistant CP70 cells were treated with cisplatin. The proliferation of cisplatin-resistant CP70 cells was observed following treatment with cisplatin. The expression of CLOCK mRNA was significantly higher in cisplatin-resistant CP70 cells (1.58±0.49) compared with cisplatin-sensitive A2780 cells (0.44±0.13) (P<0.01). Western blot assay results demonstrated that the expression of CLOCK protein was significantly greater in the cisplatin-resistant CP70 cells (1.47±0.34) compared with the cisplatin-sensitive A2780 cells (0.48±0.15) (P<0.01). Following the treatment of A2780 and CP70 cells with cisplatin, CLOCK protein expression increased with an increased concentration of cisplatin, in a dose-dependent manner (P<0.01). Following the knockdown of CLOCK in cisplatin-resistant CP70 cells by RNA interference, cisplatin treatment was able to significantly inhibit the proliferation of cells and induce apoptosis (P<0.01). The expression of circadian gene CLOCK in ovarian cancer cells was strongly associated with cisplatin resistance. The upregulation of circadian gene CLOCK in ovarian cancer cells may reduce its sensitivity to cisplatin treatment. D.A. Spandidos 2018-06 2018-04-13 /pmc/articles/PMC5958788/ /pubmed/29844814 http://dx.doi.org/10.3892/ol.2018.8488 Text en Copyright: © Xu et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Xu, Hai
Wang, Zhiyin
Mo, Guoyan
Chen, Hao
Association between circadian gene CLOCK and cisplatin resistance in ovarian cancer cells: A preliminary study
title Association between circadian gene CLOCK and cisplatin resistance in ovarian cancer cells: A preliminary study
title_full Association between circadian gene CLOCK and cisplatin resistance in ovarian cancer cells: A preliminary study
title_fullStr Association between circadian gene CLOCK and cisplatin resistance in ovarian cancer cells: A preliminary study
title_full_unstemmed Association between circadian gene CLOCK and cisplatin resistance in ovarian cancer cells: A preliminary study
title_short Association between circadian gene CLOCK and cisplatin resistance in ovarian cancer cells: A preliminary study
title_sort association between circadian gene clock and cisplatin resistance in ovarian cancer cells: a preliminary study
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958788/
https://www.ncbi.nlm.nih.gov/pubmed/29844814
http://dx.doi.org/10.3892/ol.2018.8488
work_keys_str_mv AT xuhai associationbetweencircadiangeneclockandcisplatinresistanceinovariancancercellsapreliminarystudy
AT wangzhiyin associationbetweencircadiangeneclockandcisplatinresistanceinovariancancercellsapreliminarystudy
AT moguoyan associationbetweencircadiangeneclockandcisplatinresistanceinovariancancercellsapreliminarystudy
AT chenhao associationbetweencircadiangeneclockandcisplatinresistanceinovariancancercellsapreliminarystudy